Comparison of Adding EMEND to PONV/PDNV Treatment Regimen
| Status: | Withdrawn |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 2/2/2018 |
| Start Date: | October 2010 |
| End Date: | October 2011 |
A Comparison Study to Determine the Increased Efficacy of Adding EMEND to the Treatment Regimen for Post-Discharge and Post-Operative Nausea and Vomiting
This study is looking at whether the addition of a fairly new drug for the treatment of
post-operative nausea and vomiting (PONV) and post-discharge nausea and vomiting(PDNV)will
provide added efficacy if added to 2 drugs that are already used as a standard of care for
PONV and PDNV.
The patients that will be looked at will be deemed at higher risk for PONV and PDNV based on
the procedure they are having done and/or on patient risk factors.
post-operative nausea and vomiting (PONV) and post-discharge nausea and vomiting(PDNV)will
provide added efficacy if added to 2 drugs that are already used as a standard of care for
PONV and PDNV.
The patients that will be looked at will be deemed at higher risk for PONV and PDNV based on
the procedure they are having done and/or on patient risk factors.
Inclusion Criteria:
- patients with at least 2 of the common risk factors for PONV/PDNV; patients having a
procedure deemed at high risk for PONV/PDNV
Exclusion Criteria:
- patients under 19 years of age; pregnant and breast-feeding patients
We found this trial at
1
site
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
Click here to add this to my saved trials
